(Q44966802)

7 December 2017

title

Comparative activity of cetirizine and desloratadine on histamine-induced wheal-and-flare responses during 24 hours (English)

1 reference

7 December 2017

Ashok Purohit

1

1 reference

7 December 2017

Michel Melac

series ordinal

2

1 reference

7 December 2017

Gabrielle Pauli

series ordinal

3

1 reference

7 December 2017

Nelly Frossard

series ordinal

4

1 reference

7 December 2017

language of work or name

1 reference

1 June 2004

1 reference

Annals of Allergy, Asthma & Immunology

7 December 2017

published in

1 reference

7 December 2017

volume

92

1 reference

7 December 2017

issue

6

1 reference

7 December 2017

page(s)

635-640

1 reference

Cetirizine. A reappraisal of its pharmacological properties and therapeutic use in selected allergic disorders

7 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961429-9

7 January 2021

Cetirizine. A review of its pharmacological properties and clinical potential in allergic rhinitis, pollen-induced asthma, and chronic urticaria

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961429-9

7 January 2021

Inhibition of histamine-induced nasal obstruction by cetirizine in allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961429-9

7 January 2021

Onset of action in the nasal antihistaminic effect of cetirizine and loratadine in patients with allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961429-9

7 January 2021

Nasal effect of cetirizine and loratadine at 24 hours in patients with allergic rhinitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961429-9

7 January 2021

A double-blind, single-dose, crossover comparison of cetirizine, terfenadine, loratadine, astemizole, and chlorpheniramine versus placebo: suppressive effects on histamine-induced wheals and flares during 24 hours in normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961429-9

7 January 2021

Consistency of the efficacy of cetirizine and ebastine on skin reactivity

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961429-9

7 January 2021

Consistency and efficacy of cetirizine (10 mg) versus ebastine (20 mg) at 4 h on skin reactivity

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961429-9

7 January 2021

Twenty-four hours of activity of cetirizine and fexofenadine in the skin

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961429-9

7 January 2021

Gas chromatographic method for the determination of cetirizine in plasma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961429-9

7 January 2021

The antiallergic effects of antihistamines (H1-receptor antagonists)

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961429-9

7 January 2021

Inhibitory Effects of Orally or Sublingually Administered Cetirizine on Histamine-induced Weals and Flares and Their Correlation with Cetirizine Plasma Concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961429-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961429-9

1 reference

7 January 2021

The pharmacologic profile of desloratadine: a review

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961429-9

7 January 2021

Once-daily desloratadine improves the signs and symptoms of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961429-9

7 January 2021

Desloratadine in the treatment of chronic idiopathic urticaria

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961429-9

7 January 2021

Decongestant efficacy of desloratadine in patients with seasonal allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961429-9

7 January 2021

Pharmacology and clinical efficacy of desloratadine as an anti-allergic and anti-inflammatory drug

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961429-9

7 January 2021

Precision of skin prick and puncture tests with nine methods

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961429-9

7 January 2021

Comparing the H1 profile of second-generation antihistamines

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961429-9

7 January 2021

New insights into the second generation antihistamines

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961429-9

7 January 2021

A double-blind, single-dose, crossover comparison of cetirizine, ebastine, epinastine, fexofenadine, terfenadine, and loratadine versus placebo: suppression of histamine-induced wheal and flare response for 24 h in healthy male subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961429-9

7 January 2021

The metabolism of antihistamines and drug interactions: the role of cytochrome P450 enzymes

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961429-9

7 January 2021

10.1016/S1081-1206(10)61429-9

Identifiers

DOI

1 reference

7 December 2017

1 reference